Li M - Search Results

1

Structural modifications toward improved lead-203/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors.

Lee D, Li M, Liu D, Baumhover NJ, Sagastume EA, Marks BM, Rastogi P, Pigge FC, Menda Y, Johnson FL, Schultz MK. Lee D, et al. Among authors: li m. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1147-1162. doi: 10.1007/s00259-023-06494-9. Epub 2023 Nov 13. Eur J Nucl Med Mol Imaging. 2024. PMID: 37955792 Free PMC article.

2

Automated cassette-based production of high specific activity [^203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer.

Li M, Zhang X, Quinn TP, Lee D, Liu D, Kunkel F, Zimmerman BE, McAlister D, Olewein K, Menda Y, Mirzadeh S, Copping R, Johnson FL, Schultz MK. Li M, et al. Appl Radiat Isot. 2017 Sep;127:52-60. doi: 10.1016/j.apradiso.2017.05.006. Epub 2017 May 10. Appl Radiat Isot. 2017. PMID: 28521118 Free PMC article.

3

Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.

Lee D, Li M, Bednarz B, Schultz MK. Lee D, et al. Among authors: li m. Radiat Res. 2018 Sep;190(3):236-247. doi: 10.1667/RR15081.1. Epub 2018 Jun 26. Radiat Res. 2018. PMID: 29944461 Free PMC article.

4

Optimizing the radiosynthesis of [⁶⁸Ga]DOTA-MLN6907 peptide containing three disulfide cyclization bonds - a GCC specific chelate for clinical radiopharmaceuticals.

Ghai A, Singh B, Li M, Daniels TA, Coelho R, Orcutt K, Watkins GL, Norenberg JP, Cvet D, Schultz MK. Ghai A, et al. Among authors: li m. Appl Radiat Isot. 2018 Oct;140:333-341. doi: 10.1016/j.apradiso.2018.08.006. Epub 2018 Aug 9. Appl Radiat Isot. 2018. PMID: 30138815

5

High content screening identifies monensin as an EMT-selective cytotoxic compound.

Vanneste M, Huang Q, Li M, Moose D, Zhao L, Stamnes MA, Schultz M, Wu M, Henry MD. Vanneste M, et al. Among authors: li m. Sci Rep. 2019 Feb 4;9(1):1200. doi: 10.1038/s41598-018-38019-y. Sci Rep. 2019. PMID: 30718715 Free PMC article.

6

Corrigendum to "Automated cassette-based production of high specific activity [^203/212Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancer" [Appl. Radiat. Isot. 127 (2017) 52-60].

Li M, Zhang X, Quinn TP, Lee D, Liu D, Kunkel F, Zimmerman BE, McAlister D, Olewein K, Menda Y, Mirzadeh S, Copping R, Johnson FL, Schultz MK. Li M, et al. Appl Radiat Isot. 2020 Feb;156:108733. doi: 10.1016/j.apradiso.2019.05.019. Epub 2019 Jun 12. Appl Radiat Isot. 2020. PMID: 31202737 No abstract available.

7

Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic Melanoma.

Li M, Liu D, Lee D, Kapoor S, Gibson-Corley KN, Quinn TP, Sagastume EA, Mott SL, Walsh SA, Acevedo MR, Johnson FL, Schultz MK. Li M, et al. Mol Pharm. 2019 Sep 3;16(9):3904-3915. doi: 10.1021/acs.molpharmaceut.9b00512. Epub 2019 Jul 31. Mol Pharm. 2019. PMID: 31318566 Free PMC article.

8

Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper.

Falls-Hubert KC, Butler AL, Gui K, Anderson M, Li M, Stolwijk JM, Rodman SN 3rd, Solst SR, Tomanek-Chalkley A, Searby CC, Sheffield VC, Sandfort V, Schmidt H, McCormick ML, Wels BR, Allen BG, Buettner GR, Schultz MK, Spitz DR. Falls-Hubert KC, et al. Among authors: li m. Free Radic Biol Med. 2020 Apr;150:1-11. doi: 10.1016/j.freeradbiomed.2020.01.186. Epub 2020 Feb 4. Free Radic Biol Med. 2020. PMID: 32032663 Free PMC article.

9

^203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer.

Li M, Sagastume EA, Lee D, McAlister D, DeGraffenreid AJ, Olewine KR, Graves S, Copping R, Mirzadeh S, Zimmerman BE, Larsen RH, Johnson FL, Schultz MK. Li M, et al. Curr Med Chem. 2020;27(41):7003-7031. doi: 10.2174/0929867327999200727190423. Curr Med Chem. 2020. PMID: 32720598 Free PMC article. Review.

10

Targeted Alpha-Particle Radiotherapy and Immune Checkpoint Inhibitors Induces Cooperative Inhibition on Tumor Growth of Malignant Melanoma.

Li M, Liu D, Lee D, Cheng Y, Baumhover NJ, Marks BM, Sagastume EA, Ballas ZK, Johnson FL, Morris ZS, Schultz MK. Li M, et al. Cancers (Basel). 2021 Jul 22;13(15):3676. doi: 10.3390/cancers13153676. Cancers (Basel). 2021. PMID: 34359580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,984 results

Search Page

Filters